January 23 - 24, 2018

13th Biosimilars Summit

at Hilton Alexandria Old Town in Alexandria, VA

Moving Beyond Theory — Strategic and Tactical Decisions for Long-Term Success

With more U.S. biosimilars continuing to receive FDA approval, it is critical that bio/pharmaceutical companies develop strategies to comply with evolving regulations, mitigate risk and execute long-term decisions to prepare for success. CBI’s 13th Biosimilars Summit is the leading event to continually stay on the pulse of the biosimilars’ ever-changing market and convenes key stakeholders including biosimilar and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biosimilar product success.

Who should attend:

You will benefit from attending this event if you are a vice president, director, or manager of a pharmaceutical or biotech company with responsibilities in the following areas:

  • Biosimilar Development
  • Brand/Marketing
  • Sales
  • Regulatory Affairs
  • Legal
  • Intellectual Property
  • Business Development
  • Portfolio Management
  • Corporate Strategy
  • Strategic Planning
  • Patents
  • Policy
  • Finance
  • Pricing Strategy
  • Managed Markets

This conference will also benefit pharmacies, GPOs, health systems, law firms, consultants, discovery firms and software service providers.


Hilton Alexandria Old Town
1767 King St.
Alexandria, VA
View map